ArticleDiscover oncology2026

DIAPH3 is a multifaceted prognostic biomarker that links immunotherapy response to tumor microenvironment in prostate cancer.

Yuxuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.